• Western blot analysis of various lysates, using PDCD10 rabbit polyclonal antibody (STJ119307) at 1:500 dilution. Secondary antibody: HRP Goat Anti-rabbit IgG (H+L) (STJS000856) at 1:10000 dilution. Lysates/proteins: 25 Mu g per lane. Blocking buffer: 3% non-fat dry milk in TBST. Detection: ECL Basic Kit. Exposure time: 45s.
  • Immunohistochemistry analysis of paraffin-embedded rat spleen using PDCD10 antibody (STJ119307) at dilution of 1:100 (40x lens). Perform microwave antigen retrieval with 10 mM PBS buffer pH 7. 2 before commencing with immunohistochemistry staining protocol.
  • Immunohistochemistry analysis of paraffin-embedded human breast cancer using PDCD10 antibody (STJ119307) at dilution of 1:100 (40x lens). Perform microwave antigen retrieval with 10 mM PBS buffer pH 7. 2 before commencing with immunohistochemistry staining protocol.
  • Immunohistochemistry analysis of paraffin-embedded mouse kidney using PDCD10 antibody (STJ119307) at dilution of 1:100 (40x lens). Perform microwave antigen retrieval with 10 mM PBS buffer pH 7. 2 before commencing with immunohistochemistry staining protocol.
  • Immunofluorescence analysis of PC-12 cells using PDCD10 rabbit polyclonal antibody (STJ119307) at dilution of 1:200 (40x lens). Blue: DAPI for nuclear staining.

Anti-PDCD10 antibody (1-212) (STJ119307)

SKU:
STJ119307

Shipping:
Free Shipping
Current Stock:
Host: Rabbit
Applications: WB/IHC-P/IF/ICC/ELISA
Reactivity: Human/Mouse/Rat
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: PBS with 0.05% Proclin300, 50% Glycerol, pH 7.3.
Purification: Affinity purification
Concentration: Lot specific
Dilution Range: WB:1:500-1:1000
IHC-P:1:50-1:200
IF/ICC:1:50-1:200
ELISA:Recommended starting concentration is 1 Mu g/mL. Please optimize the concentration based on your specific assay requirements.
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol: PDCD10
Gene ID: 11235
Uniprot ID: PDC10_HUMAN
Immunogen Region: 1-212
Specificity: Recombinant fusion protein containing a sequence corresponding to amino acids 1-212 of human PDCD10 (NP_009148.2).
Immunogen Sequence: MRMTMEEMKNEAETTSMVSM PLYAVMYPVFNELERVNLSA AQTLRAAFIKAEKENPGLTQ DIIMKILEKKSVEVNFTESL LRMAADDVEEYMIERPEPEF QDLNEKARALKQILSKIPDE INDRVRFLQTIKDIASAIKE LLDTVNNVFKKYQYQNRRAL EHQKKEFVKYSKSFSDTLKT YFKDGKAINVFVSANRLIHQ TNLILQTFKTVA
Tissue Specificity Ubiquitous.
Function Promotes cell proliferation. Modulates apoptotic pathways. Increases mitogen-activated protein kinase activity and STK26 activity. Important for cell migration, and for normal structure and assembly of the Golgi complex. Part of the striatin-interacting phosphatase and kinase (STRIPAK) complexes. STRIPAK complexes have critical roles in protein (de)phosphorylation and are regulators of multiple signaling pathways including Hippo, MAPK, nuclear receptor and cytoskeleton remodeling. Different types of STRIPAK complexes are involved in a variety of biological processes such as cell growth, differentiation, apoptosis, metabolism and immune regulation. Important for KDR/VEGFR2 signaling. Increases the stability of KDR/VEGFR2 and prevents its breakdown. Required for normal cardiovascular development. Required for normal angiogenesis, vasculogenesis and hematopoiesis during embryonic development.
Protein Name Programmed Cell Death Protein 10
Cerebral Cavernous Malformations 3 Protein
Tf-1 Cell Apoptosis-Related Protein 15
Cellular Localisation Cytoplasm
Golgi Apparatus Membrane
Peripheral Membrane Protein
Cytoplasmic Side
Cell Membrane
Alternative Antibody Names Anti-Programmed Cell Death Protein 10 antibody
Anti-Cerebral Cavernous Malformations 3 Protein antibody
Anti-Tf-1 Cell Apoptosis-Related Protein 15 antibody
Anti-PDCD10 antibody
Anti-CCM3 antibody
Anti-TFAR15 antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance